Grant Details

General Overview

Grant Information

Grant Name: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research

Funding Organization: National Cancer Institute (NCI), National Institutes of Health (NIH)

Total Funding Amount: $4,200,000

Duration: Up to 3 years

Primary Objective: Support exploratory research projects focused on innovative technologies for cancer research.

Key Stakeholders: Researchers in cancer biology, clinical diagnosis, treatment, and epidemiology.

Funding Source: Federal government (NIH).

Significance: Part of the broader Innovative Molecular Analysis Technologies (IMAT) Program.

Grant Frequency: One-time funding opportunity.

Organizational Aspects

Eligible Organization Types

Higher Education Institutions

Public/State Controlled Institutions of Higher Education

Private Institutions of Higher Education

Nonprofits (with or without 501(c)(3) status)

For-Profit Organizations (including Small Businesses)

Local, State, County, City Governments

Indian/Native American Tribal Governments (both Federally Recognized and others)

Federal Government Agencies

Foreign Organizations

Specific Qualifications

No specific qualifications or certifications required.

Organizations must complete necessary registrations (SAM, eRA Commons) prior to application.

Scope and Focus

Primary Focus Areas

Development of innovative technologies for molecular and cellular analysis in cancer research.

Technologies must enhance research in cancer biology, early detection, clinical diagnosis, treatment, and epidemiology.

Expected Outcomes

Technologies should demonstrate potential for substantial improvements over existing methods.

Applications must include quantitative performance measures.

Technical Details

Technical Expertise Requirements

No specific technical expertise required, but projects must demonstrate innovative approaches.

Financial Structure

Budget and Funding Limits

Maximum grant amount: $150,000 per year.

Total project period may not exceed 3 years.

Timeline and Implementation

Submission Deadlines

Application Due Date: October 3, 2025.

Open Date: March 4, 2025.

Compliance and Requirements

Regulatory Compliance

Must comply with NIH Grants Policy Statement and federal regulations.

Application Process

Required Documentation

Follow instructions in the Research (R) Instructions in the How to Apply - Application Guide.

Grant Details

cancer tumor healthcare biotech medical research technology development clinical research epidemiology innovation molecular analysis
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
RFA-CA-25-001
Innovative Molecular Analysis Technologies (IMAT) Program
EDU NGO ENTERPRISE PUBLIC RESEARCH SME OTHER
US
HEALTHCARE TECHNOLOGY OTHER
IDEA DEVELOPMENT
0-10 11-50 51-250 251-500 500+
SDG3
FUNDING RESEARCH_DEVELOPMENT
None
4200000.00
150000.00
150000.00
USD
100.00
Oct. 3, 2025, 10 p.m.
July 2025 - October 2025